EUROPEAN JOURNAL OF CLINICAL NUTRITION-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1236754, encodeId=2b1d1236e54a7, content=前天投了一篇，今天已经被拒，速度可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5fd51628848, createdName=zsycxy, createdTime=Fri Aug 05 11:39:16 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191244, encodeId=fff71191244d9, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：营养 经验分享：4th Jul 21 第一次提交 20th Aug 21 第一次返回意见 6th Sep 21 修回 20th Dec 21 第二次返回意见 9th Jan 22 修回 26th Jan 22 审稿人看完了又回到编辑手里了，但是迟迟没做决定/摊手/摊手/摊手 太慢了，这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5f71952119, createdName=嗷大喵haha, createdTime=Tue Feb 08 22:20:59 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589174, encodeId=82505891e4c7, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：meta分析 2019.8.23投稿 2019.11.4 一修 2020.1.6接收并二修 2020.1.17三修 2020.2.19接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7ccb5091546, createdName=145d4526m90(暂无昵称), createdTime=Sat Apr 18 00:00:00 CST 2020, time=2020-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902029, encodeId=a28d902029d1, content=请问过来人，投稿后只有通讯才能收到邮件吗？投稿的几个状态是啥？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=两难不难, createdTime=Wed Nov 25 07:53:35 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187768, encodeId=70b9118e76879, content=偏重的研究方向：临床营养 经验分享：EJCN meta分析投稿过程 2019.8.23投稿 2019.11.4 一修，12.17日返回修改稿 2020.1.6接收并二修，1.13返回 2020.1.17三修，1.20返回（有关通讯作者的小插曲） 2020.2.19接收 2020.2.28清样校队（未收到邮件，2.9日返回清样修改） 2020.3.13 EJCN上见刊 pubmed检索到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7ccb5091546, createdName=145d4526m90(暂无昵称), createdTime=Mon Jan 24 18:45:49 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090233, encodeId=46501090233c8, content=什么叫俢回？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090234, encodeId=371b109023434, content=俢回包括几个方面？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600232, encodeId=9c6d60023229, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：20.02.19 接收 20.02.11 decision 小修 20.01.27 一修提交 19.12.14 Waiting for Revision（due on 20.03.12）大修 19.09.17 in review (under review) 19.07.24 submission , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=09535185854, createdName=14707d35m85暂无昵称, createdTime=Sat May 23 10:53:10 CST 2020, time=2020-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581432, encodeId=e6315814326e, content=怎么就一个review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuCa1ZaFh5Zdh1foqG1yB0ykFycWxPtg8y2iaVXY2KzrTc2R2UzasWspet9CmDHK0FJkutZYBvF7fx/0, createdBy=9fdd2081770, createdName=1521f25362m, createdTime=Fri Dec 13 00:00:00 CST 2019, time=2019-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564560, encodeId=4aed56456067, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：Meta 分析。18.11.21投稿，当即编辑发来邮件要求修改格式，连续修改了三次总算过格式关。11.28日通知通过初审送外审。11.17日退稿。俩审稿人都给了不多但很中肯的意见（可能我水平太差懒得多提），我也认识自己的差距，准备好好改投别家。都一致评我英语太差。总体来说效率很高，没有耽误太久，编辑来信中也提到中稿率约25%。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKJ73fWSxHh3xvG6CRmkSC454TlmZGCL5nXyJYuwwrvJtX7y37Q0W3jVTNKAXJvK0cZlXW85O4BdQ/132, createdBy=13532450097, createdName=王尛象, createdTime=Mon Dec 17 00:00:00 CST 2018, time=2018-12-17, status=1, ipAttribution=)]

2022-08-05 zsycxy

前天投了一篇，今天已经被拒，速度可以

59 0

[GetPortalCommentsPageByObjectIdResponse(id=1236754, encodeId=2b1d1236e54a7, content=前天投了一篇，今天已经被拒，速度可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5fd51628848, createdName=zsycxy, createdTime=Fri Aug 05 11:39:16 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191244, encodeId=fff71191244d9, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：营养 经验分享：4th Jul 21 第一次提交 20th Aug 21 第一次返回意见 6th Sep 21 修回 20th Dec 21 第二次返回意见 9th Jan 22 修回 26th Jan 22 审稿人看完了又回到编辑手里了，但是迟迟没做决定/摊手/摊手/摊手 太慢了，这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5f71952119, createdName=嗷大喵haha, createdTime=Tue Feb 08 22:20:59 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589174, encodeId=82505891e4c7, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：meta分析 2019.8.23投稿 2019.11.4 一修 2020.1.6接收并二修 2020.1.17三修 2020.2.19接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7ccb5091546, createdName=145d4526m90(暂无昵称), createdTime=Sat Apr 18 00:00:00 CST 2020, time=2020-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902029, encodeId=a28d902029d1, content=请问过来人，投稿后只有通讯才能收到邮件吗？投稿的几个状态是啥？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=两难不难, createdTime=Wed Nov 25 07:53:35 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187768, encodeId=70b9118e76879, content=偏重的研究方向：临床营养 经验分享：EJCN meta分析投稿过程 2019.8.23投稿 2019.11.4 一修，12.17日返回修改稿 2020.1.6接收并二修，1.13返回 2020.1.17三修，1.20返回（有关通讯作者的小插曲） 2020.2.19接收 2020.2.28清样校队（未收到邮件，2.9日返回清样修改） 2020.3.13 EJCN上见刊 pubmed检索到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7ccb5091546, createdName=145d4526m90(暂无昵称), createdTime=Mon Jan 24 18:45:49 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090233, encodeId=46501090233c8, content=什么叫俢回？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090234, encodeId=371b109023434, content=俢回包括几个方面？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600232, encodeId=9c6d60023229, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：20.02.19 接收 20.02.11 decision 小修 20.01.27 一修提交 19.12.14 Waiting for Revision（due on 20.03.12）大修 19.09.17 in review (under review) 19.07.24 submission , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=09535185854, createdName=14707d35m85暂无昵称, createdTime=Sat May 23 10:53:10 CST 2020, time=2020-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581432, encodeId=e6315814326e, content=怎么就一个review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuCa1ZaFh5Zdh1foqG1yB0ykFycWxPtg8y2iaVXY2KzrTc2R2UzasWspet9CmDHK0FJkutZYBvF7fx/0, createdBy=9fdd2081770, createdName=1521f25362m, createdTime=Fri Dec 13 00:00:00 CST 2019, time=2019-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564560, encodeId=4aed56456067, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：Meta 分析。18.11.21投稿，当即编辑发来邮件要求修改格式，连续修改了三次总算过格式关。11.28日通知通过初审送外审。11.17日退稿。俩审稿人都给了不多但很中肯的意见（可能我水平太差懒得多提），我也认识自己的差距，准备好好改投别家。都一致评我英语太差。总体来说效率很高，没有耽误太久，编辑来信中也提到中稿率约25%。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKJ73fWSxHh3xvG6CRmkSC454TlmZGCL5nXyJYuwwrvJtX7y37Q0W3jVTNKAXJvK0cZlXW85O4BdQ/132, createdBy=13532450097, createdName=王尛象, createdTime=Mon Dec 17 00:00:00 CST 2018, time=2018-12-17, status=1, ipAttribution=)]

2022-02-08 嗷大喵haha

审稿速度:12.0 | 投稿命中率:50.0
偏重的研究方向：营养
经验分享：4th Jul 21 第一次提交
20th Aug 21 第一次返回意见
6th Sep 21 修回
20th Dec 21 第二次返回意见
9th Jan 22 修回
26th Jan 22 审稿人看完了又回到编辑手里了，但是迟迟没做决定/摊手/摊手/摊手
太慢了，这个期刊

100 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1236754, encodeId=2b1d1236e54a7, content=前天投了一篇，今天已经被拒，速度可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5fd51628848, createdName=zsycxy, createdTime=Fri Aug 05 11:39:16 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191244, encodeId=fff71191244d9, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：营养 经验分享：4th Jul 21 第一次提交 20th Aug 21 第一次返回意见 6th Sep 21 修回 20th Dec 21 第二次返回意见 9th Jan 22 修回 26th Jan 22 审稿人看完了又回到编辑手里了，但是迟迟没做决定/摊手/摊手/摊手 太慢了，这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5f71952119, createdName=嗷大喵haha, createdTime=Tue Feb 08 22:20:59 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589174, encodeId=82505891e4c7, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：meta分析 2019.8.23投稿 2019.11.4 一修 2020.1.6接收并二修 2020.1.17三修 2020.2.19接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7ccb5091546, createdName=145d4526m90(暂无昵称), createdTime=Sat Apr 18 00:00:00 CST 2020, time=2020-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902029, encodeId=a28d902029d1, content=请问过来人，投稿后只有通讯才能收到邮件吗？投稿的几个状态是啥？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=两难不难, createdTime=Wed Nov 25 07:53:35 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187768, encodeId=70b9118e76879, content=偏重的研究方向：临床营养 经验分享：EJCN meta分析投稿过程 2019.8.23投稿 2019.11.4 一修，12.17日返回修改稿 2020.1.6接收并二修，1.13返回 2020.1.17三修，1.20返回（有关通讯作者的小插曲） 2020.2.19接收 2020.2.28清样校队（未收到邮件，2.9日返回清样修改） 2020.3.13 EJCN上见刊 pubmed检索到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7ccb5091546, createdName=145d4526m90(暂无昵称), createdTime=Mon Jan 24 18:45:49 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090233, encodeId=46501090233c8, content=什么叫俢回？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090234, encodeId=371b109023434, content=俢回包括几个方面？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600232, encodeId=9c6d60023229, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：20.02.19 接收 20.02.11 decision 小修 20.01.27 一修提交 19.12.14 Waiting for Revision（due on 20.03.12）大修 19.09.17 in review (under review) 19.07.24 submission , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=09535185854, createdName=14707d35m85暂无昵称, createdTime=Sat May 23 10:53:10 CST 2020, time=2020-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581432, encodeId=e6315814326e, content=怎么就一个review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuCa1ZaFh5Zdh1foqG1yB0ykFycWxPtg8y2iaVXY2KzrTc2R2UzasWspet9CmDHK0FJkutZYBvF7fx/0, createdBy=9fdd2081770, createdName=1521f25362m, createdTime=Fri Dec 13 00:00:00 CST 2019, time=2019-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564560, encodeId=4aed56456067, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：Meta 分析。18.11.21投稿，当即编辑发来邮件要求修改格式，连续修改了三次总算过格式关。11.28日通知通过初审送外审。11.17日退稿。俩审稿人都给了不多但很中肯的意见（可能我水平太差懒得多提），我也认识自己的差距，准备好好改投别家。都一致评我英语太差。总体来说效率很高，没有耽误太久，编辑来信中也提到中稿率约25%。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKJ73fWSxHh3xvG6CRmkSC454TlmZGCL5nXyJYuwwrvJtX7y37Q0W3jVTNKAXJvK0cZlXW85O4BdQ/132, createdBy=13532450097, createdName=王尛象, createdTime=Mon Dec 17 00:00:00 CST 2018, time=2018-12-17, status=1, ipAttribution=)]

2020-04-18 145d4526m90(暂无昵称)

审稿速度:3.0 | 投稿命中率:50.0
经验分享：meta分析 2019.8.23投稿 2019.11.4 一修 2020.1.6接收并二修 2020.1.17三修 2020.2.19接收

182 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=1236754, encodeId=2b1d1236e54a7, content=前天投了一篇，今天已经被拒，速度可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5fd51628848, createdName=zsycxy, createdTime=Fri Aug 05 11:39:16 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191244, encodeId=fff71191244d9, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：营养 经验分享：4th Jul 21 第一次提交 20th Aug 21 第一次返回意见 6th Sep 21 修回 20th Dec 21 第二次返回意见 9th Jan 22 修回 26th Jan 22 审稿人看完了又回到编辑手里了，但是迟迟没做决定/摊手/摊手/摊手 太慢了，这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5f71952119, createdName=嗷大喵haha, createdTime=Tue Feb 08 22:20:59 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589174, encodeId=82505891e4c7, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：meta分析 2019.8.23投稿 2019.11.4 一修 2020.1.6接收并二修 2020.1.17三修 2020.2.19接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7ccb5091546, createdName=145d4526m90(暂无昵称), createdTime=Sat Apr 18 00:00:00 CST 2020, time=2020-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902029, encodeId=a28d902029d1, content=请问过来人，投稿后只有通讯才能收到邮件吗？投稿的几个状态是啥？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=两难不难, createdTime=Wed Nov 25 07:53:35 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187768, encodeId=70b9118e76879, content=偏重的研究方向：临床营养 经验分享：EJCN meta分析投稿过程 2019.8.23投稿 2019.11.4 一修，12.17日返回修改稿 2020.1.6接收并二修，1.13返回 2020.1.17三修，1.20返回（有关通讯作者的小插曲） 2020.2.19接收 2020.2.28清样校队（未收到邮件，2.9日返回清样修改） 2020.3.13 EJCN上见刊 pubmed检索到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7ccb5091546, createdName=145d4526m90(暂无昵称), createdTime=Mon Jan 24 18:45:49 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090233, encodeId=46501090233c8, content=什么叫俢回？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090234, encodeId=371b109023434, content=俢回包括几个方面？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600232, encodeId=9c6d60023229, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：20.02.19 接收 20.02.11 decision 小修 20.01.27 一修提交 19.12.14 Waiting for Revision（due on 20.03.12）大修 19.09.17 in review (under review) 19.07.24 submission , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=09535185854, createdName=14707d35m85暂无昵称, createdTime=Sat May 23 10:53:10 CST 2020, time=2020-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581432, encodeId=e6315814326e, content=怎么就一个review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuCa1ZaFh5Zdh1foqG1yB0ykFycWxPtg8y2iaVXY2KzrTc2R2UzasWspet9CmDHK0FJkutZYBvF7fx/0, createdBy=9fdd2081770, createdName=1521f25362m, createdTime=Fri Dec 13 00:00:00 CST 2019, time=2019-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564560, encodeId=4aed56456067, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：Meta 分析。18.11.21投稿，当即编辑发来邮件要求修改格式，连续修改了三次总算过格式关。11.28日通知通过初审送外审。11.17日退稿。俩审稿人都给了不多但很中肯的意见（可能我水平太差懒得多提），我也认识自己的差距，准备好好改投别家。都一致评我英语太差。总体来说效率很高，没有耽误太久，编辑来信中也提到中稿率约25%。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKJ73fWSxHh3xvG6CRmkSC454TlmZGCL5nXyJYuwwrvJtX7y37Q0W3jVTNKAXJvK0cZlXW85O4BdQ/132, createdBy=13532450097, createdName=王尛象, createdTime=Mon Dec 17 00:00:00 CST 2018, time=2018-12-17, status=1, ipAttribution=)]

2020-11-25 两难不难

请问过来人，投稿后只有通讯才能收到邮件吗？投稿的几个状态是啥？谢谢

152 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1236754, encodeId=2b1d1236e54a7, content=前天投了一篇，今天已经被拒，速度可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5fd51628848, createdName=zsycxy, createdTime=Fri Aug 05 11:39:16 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191244, encodeId=fff71191244d9, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：营养 经验分享：4th Jul 21 第一次提交 20th Aug 21 第一次返回意见 6th Sep 21 修回 20th Dec 21 第二次返回意见 9th Jan 22 修回 26th Jan 22 审稿人看完了又回到编辑手里了，但是迟迟没做决定/摊手/摊手/摊手 太慢了，这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5f71952119, createdName=嗷大喵haha, createdTime=Tue Feb 08 22:20:59 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589174, encodeId=82505891e4c7, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：meta分析 2019.8.23投稿 2019.11.4 一修 2020.1.6接收并二修 2020.1.17三修 2020.2.19接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7ccb5091546, createdName=145d4526m90(暂无昵称), createdTime=Sat Apr 18 00:00:00 CST 2020, time=2020-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902029, encodeId=a28d902029d1, content=请问过来人，投稿后只有通讯才能收到邮件吗？投稿的几个状态是啥？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=两难不难, createdTime=Wed Nov 25 07:53:35 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187768, encodeId=70b9118e76879, content=偏重的研究方向：临床营养 经验分享：EJCN meta分析投稿过程 2019.8.23投稿 2019.11.4 一修，12.17日返回修改稿 2020.1.6接收并二修，1.13返回 2020.1.17三修，1.20返回（有关通讯作者的小插曲） 2020.2.19接收 2020.2.28清样校队（未收到邮件，2.9日返回清样修改） 2020.3.13 EJCN上见刊 pubmed检索到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7ccb5091546, createdName=145d4526m90(暂无昵称), createdTime=Mon Jan 24 18:45:49 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090233, encodeId=46501090233c8, content=什么叫俢回？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090234, encodeId=371b109023434, content=俢回包括几个方面？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600232, encodeId=9c6d60023229, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：20.02.19 接收 20.02.11 decision 小修 20.01.27 一修提交 19.12.14 Waiting for Revision（due on 20.03.12）大修 19.09.17 in review (under review) 19.07.24 submission , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=09535185854, createdName=14707d35m85暂无昵称, createdTime=Sat May 23 10:53:10 CST 2020, time=2020-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581432, encodeId=e6315814326e, content=怎么就一个review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuCa1ZaFh5Zdh1foqG1yB0ykFycWxPtg8y2iaVXY2KzrTc2R2UzasWspet9CmDHK0FJkutZYBvF7fx/0, createdBy=9fdd2081770, createdName=1521f25362m, createdTime=Fri Dec 13 00:00:00 CST 2019, time=2019-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564560, encodeId=4aed56456067, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：Meta 分析。18.11.21投稿，当即编辑发来邮件要求修改格式，连续修改了三次总算过格式关。11.28日通知通过初审送外审。11.17日退稿。俩审稿人都给了不多但很中肯的意见（可能我水平太差懒得多提），我也认识自己的差距，准备好好改投别家。都一致评我英语太差。总体来说效率很高，没有耽误太久，编辑来信中也提到中稿率约25%。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKJ73fWSxHh3xvG6CRmkSC454TlmZGCL5nXyJYuwwrvJtX7y37Q0W3jVTNKAXJvK0cZlXW85O4BdQ/132, createdBy=13532450097, createdName=王尛象, createdTime=Mon Dec 17 00:00:00 CST 2018, time=2018-12-17, status=1, ipAttribution=)]

2022-01-24 145d4526m90(暂无昵称)

偏重的研究方向：临床营养
经验分享：EJCN meta分析投稿过程 2019.8.23投稿 2019.11.4 一修，12.17日返回修改稿 2020.1.6接收并二修，1.13返回 2020.1.17三修，1.20返回（有关通讯作者的小插曲） 2020.2.19接收 2020.2.28清样校队（未收到邮件，2.9日返回清样修改） 2020.3.13 EJCN上见刊 pubmed检索到

111 0

[GetPortalCommentsPageByObjectIdResponse(id=1236754, encodeId=2b1d1236e54a7, content=前天投了一篇，今天已经被拒，速度可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5fd51628848, createdName=zsycxy, createdTime=Fri Aug 05 11:39:16 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191244, encodeId=fff71191244d9, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：营养 经验分享：4th Jul 21 第一次提交 20th Aug 21 第一次返回意见 6th Sep 21 修回 20th Dec 21 第二次返回意见 9th Jan 22 修回 26th Jan 22 审稿人看完了又回到编辑手里了，但是迟迟没做决定/摊手/摊手/摊手 太慢了，这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5f71952119, createdName=嗷大喵haha, createdTime=Tue Feb 08 22:20:59 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589174, encodeId=82505891e4c7, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：meta分析 2019.8.23投稿 2019.11.4 一修 2020.1.6接收并二修 2020.1.17三修 2020.2.19接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7ccb5091546, createdName=145d4526m90(暂无昵称), createdTime=Sat Apr 18 00:00:00 CST 2020, time=2020-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902029, encodeId=a28d902029d1, content=请问过来人，投稿后只有通讯才能收到邮件吗？投稿的几个状态是啥？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=两难不难, createdTime=Wed Nov 25 07:53:35 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187768, encodeId=70b9118e76879, content=偏重的研究方向：临床营养 经验分享：EJCN meta分析投稿过程 2019.8.23投稿 2019.11.4 一修，12.17日返回修改稿 2020.1.6接收并二修，1.13返回 2020.1.17三修，1.20返回（有关通讯作者的小插曲） 2020.2.19接收 2020.2.28清样校队（未收到邮件，2.9日返回清样修改） 2020.3.13 EJCN上见刊 pubmed检索到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7ccb5091546, createdName=145d4526m90(暂无昵称), createdTime=Mon Jan 24 18:45:49 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090233, encodeId=46501090233c8, content=什么叫俢回？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090234, encodeId=371b109023434, content=俢回包括几个方面？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600232, encodeId=9c6d60023229, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：20.02.19 接收 20.02.11 decision 小修 20.01.27 一修提交 19.12.14 Waiting for Revision（due on 20.03.12）大修 19.09.17 in review (under review) 19.07.24 submission , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=09535185854, createdName=14707d35m85暂无昵称, createdTime=Sat May 23 10:53:10 CST 2020, time=2020-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581432, encodeId=e6315814326e, content=怎么就一个review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuCa1ZaFh5Zdh1foqG1yB0ykFycWxPtg8y2iaVXY2KzrTc2R2UzasWspet9CmDHK0FJkutZYBvF7fx/0, createdBy=9fdd2081770, createdName=1521f25362m, createdTime=Fri Dec 13 00:00:00 CST 2019, time=2019-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564560, encodeId=4aed56456067, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：Meta 分析。18.11.21投稿，当即编辑发来邮件要求修改格式，连续修改了三次总算过格式关。11.28日通知通过初审送外审。11.17日退稿。俩审稿人都给了不多但很中肯的意见（可能我水平太差懒得多提），我也认识自己的差距，准备好好改投别家。都一致评我英语太差。总体来说效率很高，没有耽误太久，编辑来信中也提到中稿率约25%。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKJ73fWSxHh3xvG6CRmkSC454TlmZGCL5nXyJYuwwrvJtX7y37Q0W3jVTNKAXJvK0cZlXW85O4BdQ/132, createdBy=13532450097, createdName=王尛象, createdTime=Mon Dec 17 00:00:00 CST 2018, time=2018-12-17, status=1, ipAttribution=)]

2021-12-29 乌云背后的幸福线

什么叫俢回？

132 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1236754, encodeId=2b1d1236e54a7, content=前天投了一篇，今天已经被拒，速度可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5fd51628848, createdName=zsycxy, createdTime=Fri Aug 05 11:39:16 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191244, encodeId=fff71191244d9, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：营养 经验分享：4th Jul 21 第一次提交 20th Aug 21 第一次返回意见 6th Sep 21 修回 20th Dec 21 第二次返回意见 9th Jan 22 修回 26th Jan 22 审稿人看完了又回到编辑手里了，但是迟迟没做决定/摊手/摊手/摊手 太慢了，这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5f71952119, createdName=嗷大喵haha, createdTime=Tue Feb 08 22:20:59 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589174, encodeId=82505891e4c7, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：meta分析 2019.8.23投稿 2019.11.4 一修 2020.1.6接收并二修 2020.1.17三修 2020.2.19接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7ccb5091546, createdName=145d4526m90(暂无昵称), createdTime=Sat Apr 18 00:00:00 CST 2020, time=2020-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902029, encodeId=a28d902029d1, content=请问过来人，投稿后只有通讯才能收到邮件吗？投稿的几个状态是啥？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=两难不难, createdTime=Wed Nov 25 07:53:35 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187768, encodeId=70b9118e76879, content=偏重的研究方向：临床营养 经验分享：EJCN meta分析投稿过程 2019.8.23投稿 2019.11.4 一修，12.17日返回修改稿 2020.1.6接收并二修，1.13返回 2020.1.17三修，1.20返回（有关通讯作者的小插曲） 2020.2.19接收 2020.2.28清样校队（未收到邮件，2.9日返回清样修改） 2020.3.13 EJCN上见刊 pubmed检索到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7ccb5091546, createdName=145d4526m90(暂无昵称), createdTime=Mon Jan 24 18:45:49 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090233, encodeId=46501090233c8, content=什么叫俢回？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090234, encodeId=371b109023434, content=俢回包括几个方面？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600232, encodeId=9c6d60023229, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：20.02.19 接收 20.02.11 decision 小修 20.01.27 一修提交 19.12.14 Waiting for Revision（due on 20.03.12）大修 19.09.17 in review (under review) 19.07.24 submission , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=09535185854, createdName=14707d35m85暂无昵称, createdTime=Sat May 23 10:53:10 CST 2020, time=2020-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581432, encodeId=e6315814326e, content=怎么就一个review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuCa1ZaFh5Zdh1foqG1yB0ykFycWxPtg8y2iaVXY2KzrTc2R2UzasWspet9CmDHK0FJkutZYBvF7fx/0, createdBy=9fdd2081770, createdName=1521f25362m, createdTime=Fri Dec 13 00:00:00 CST 2019, time=2019-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564560, encodeId=4aed56456067, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：Meta 分析。18.11.21投稿，当即编辑发来邮件要求修改格式，连续修改了三次总算过格式关。11.28日通知通过初审送外审。11.17日退稿。俩审稿人都给了不多但很中肯的意见（可能我水平太差懒得多提），我也认识自己的差距，准备好好改投别家。都一致评我英语太差。总体来说效率很高，没有耽误太久，编辑来信中也提到中稿率约25%。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKJ73fWSxHh3xvG6CRmkSC454TlmZGCL5nXyJYuwwrvJtX7y37Q0W3jVTNKAXJvK0cZlXW85O4BdQ/132, createdBy=13532450097, createdName=王尛象, createdTime=Mon Dec 17 00:00:00 CST 2018, time=2018-12-17, status=1, ipAttribution=)]

2021-12-27 桑晒麦拉

俢回包括几个方面？

88 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1236754, encodeId=2b1d1236e54a7, content=前天投了一篇，今天已经被拒，速度可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5fd51628848, createdName=zsycxy, createdTime=Fri Aug 05 11:39:16 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191244, encodeId=fff71191244d9, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：营养 经验分享：4th Jul 21 第一次提交 20th Aug 21 第一次返回意见 6th Sep 21 修回 20th Dec 21 第二次返回意见 9th Jan 22 修回 26th Jan 22 审稿人看完了又回到编辑手里了，但是迟迟没做决定/摊手/摊手/摊手 太慢了，这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5f71952119, createdName=嗷大喵haha, createdTime=Tue Feb 08 22:20:59 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589174, encodeId=82505891e4c7, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：meta分析 2019.8.23投稿 2019.11.4 一修 2020.1.6接收并二修 2020.1.17三修 2020.2.19接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7ccb5091546, createdName=145d4526m90(暂无昵称), createdTime=Sat Apr 18 00:00:00 CST 2020, time=2020-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902029, encodeId=a28d902029d1, content=请问过来人，投稿后只有通讯才能收到邮件吗？投稿的几个状态是啥？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=两难不难, createdTime=Wed Nov 25 07:53:35 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187768, encodeId=70b9118e76879, content=偏重的研究方向：临床营养 经验分享：EJCN meta分析投稿过程 2019.8.23投稿 2019.11.4 一修，12.17日返回修改稿 2020.1.6接收并二修，1.13返回 2020.1.17三修，1.20返回（有关通讯作者的小插曲） 2020.2.19接收 2020.2.28清样校队（未收到邮件，2.9日返回清样修改） 2020.3.13 EJCN上见刊 pubmed检索到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7ccb5091546, createdName=145d4526m90(暂无昵称), createdTime=Mon Jan 24 18:45:49 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090233, encodeId=46501090233c8, content=什么叫俢回？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090234, encodeId=371b109023434, content=俢回包括几个方面？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600232, encodeId=9c6d60023229, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：20.02.19 接收 20.02.11 decision 小修 20.01.27 一修提交 19.12.14 Waiting for Revision（due on 20.03.12）大修 19.09.17 in review (under review) 19.07.24 submission , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=09535185854, createdName=14707d35m85暂无昵称, createdTime=Sat May 23 10:53:10 CST 2020, time=2020-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581432, encodeId=e6315814326e, content=怎么就一个review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuCa1ZaFh5Zdh1foqG1yB0ykFycWxPtg8y2iaVXY2KzrTc2R2UzasWspet9CmDHK0FJkutZYBvF7fx/0, createdBy=9fdd2081770, createdName=1521f25362m, createdTime=Fri Dec 13 00:00:00 CST 2019, time=2019-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564560, encodeId=4aed56456067, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：Meta 分析。18.11.21投稿，当即编辑发来邮件要求修改格式，连续修改了三次总算过格式关。11.28日通知通过初审送外审。11.17日退稿。俩审稿人都给了不多但很中肯的意见（可能我水平太差懒得多提），我也认识自己的差距，准备好好改投别家。都一致评我英语太差。总体来说效率很高，没有耽误太久，编辑来信中也提到中稿率约25%。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKJ73fWSxHh3xvG6CRmkSC454TlmZGCL5nXyJYuwwrvJtX7y37Q0W3jVTNKAXJvK0cZlXW85O4BdQ/132, createdBy=13532450097, createdName=王尛象, createdTime=Mon Dec 17 00:00:00 CST 2018, time=2018-12-17, status=1, ipAttribution=)]

2020-05-23 14707d35m85暂无昵称

审稿速度:3.0 | 投稿命中率:25.0
经验分享：20.02.19 接收 20.02.11 decision 小修 20.01.27 一修提交 19.12.14 Waiting for Revision（due on 20.03.12）大修 19.09.17 in review (under review) 19.07.24 submission

185 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1236754, encodeId=2b1d1236e54a7, content=前天投了一篇，今天已经被拒，速度可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5fd51628848, createdName=zsycxy, createdTime=Fri Aug 05 11:39:16 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191244, encodeId=fff71191244d9, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：营养 经验分享：4th Jul 21 第一次提交 20th Aug 21 第一次返回意见 6th Sep 21 修回 20th Dec 21 第二次返回意见 9th Jan 22 修回 26th Jan 22 审稿人看完了又回到编辑手里了，但是迟迟没做决定/摊手/摊手/摊手 太慢了，这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5f71952119, createdName=嗷大喵haha, createdTime=Tue Feb 08 22:20:59 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589174, encodeId=82505891e4c7, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：meta分析 2019.8.23投稿 2019.11.4 一修 2020.1.6接收并二修 2020.1.17三修 2020.2.19接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7ccb5091546, createdName=145d4526m90(暂无昵称), createdTime=Sat Apr 18 00:00:00 CST 2020, time=2020-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902029, encodeId=a28d902029d1, content=请问过来人，投稿后只有通讯才能收到邮件吗？投稿的几个状态是啥？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=两难不难, createdTime=Wed Nov 25 07:53:35 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187768, encodeId=70b9118e76879, content=偏重的研究方向：临床营养 经验分享：EJCN meta分析投稿过程 2019.8.23投稿 2019.11.4 一修，12.17日返回修改稿 2020.1.6接收并二修，1.13返回 2020.1.17三修，1.20返回（有关通讯作者的小插曲） 2020.2.19接收 2020.2.28清样校队（未收到邮件，2.9日返回清样修改） 2020.3.13 EJCN上见刊 pubmed检索到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7ccb5091546, createdName=145d4526m90(暂无昵称), createdTime=Mon Jan 24 18:45:49 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090233, encodeId=46501090233c8, content=什么叫俢回？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090234, encodeId=371b109023434, content=俢回包括几个方面？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600232, encodeId=9c6d60023229, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：20.02.19 接收 20.02.11 decision 小修 20.01.27 一修提交 19.12.14 Waiting for Revision（due on 20.03.12）大修 19.09.17 in review (under review) 19.07.24 submission , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=09535185854, createdName=14707d35m85暂无昵称, createdTime=Sat May 23 10:53:10 CST 2020, time=2020-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581432, encodeId=e6315814326e, content=怎么就一个review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuCa1ZaFh5Zdh1foqG1yB0ykFycWxPtg8y2iaVXY2KzrTc2R2UzasWspet9CmDHK0FJkutZYBvF7fx/0, createdBy=9fdd2081770, createdName=1521f25362m, createdTime=Fri Dec 13 00:00:00 CST 2019, time=2019-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564560, encodeId=4aed56456067, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：Meta 分析。18.11.21投稿，当即编辑发来邮件要求修改格式，连续修改了三次总算过格式关。11.28日通知通过初审送外审。11.17日退稿。俩审稿人都给了不多但很中肯的意见（可能我水平太差懒得多提），我也认识自己的差距，准备好好改投别家。都一致评我英语太差。总体来说效率很高，没有耽误太久，编辑来信中也提到中稿率约25%。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKJ73fWSxHh3xvG6CRmkSC454TlmZGCL5nXyJYuwwrvJtX7y37Q0W3jVTNKAXJvK0cZlXW85O4BdQ/132, createdBy=13532450097, createdName=王尛象, createdTime=Mon Dec 17 00:00:00 CST 2018, time=2018-12-17, status=1, ipAttribution=)]

2019-12-13 1521f25362m

怎么就一个review

124 0

[GetPortalCommentsPageByObjectIdResponse(id=1236754, encodeId=2b1d1236e54a7, content=前天投了一篇，今天已经被拒，速度可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5fd51628848, createdName=zsycxy, createdTime=Fri Aug 05 11:39:16 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191244, encodeId=fff71191244d9, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：营养 经验分享：4th Jul 21 第一次提交 20th Aug 21 第一次返回意见 6th Sep 21 修回 20th Dec 21 第二次返回意见 9th Jan 22 修回 26th Jan 22 审稿人看完了又回到编辑手里了，但是迟迟没做决定/摊手/摊手/摊手 太慢了，这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5f71952119, createdName=嗷大喵haha, createdTime=Tue Feb 08 22:20:59 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589174, encodeId=82505891e4c7, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：meta分析 2019.8.23投稿 2019.11.4 一修 2020.1.6接收并二修 2020.1.17三修 2020.2.19接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7ccb5091546, createdName=145d4526m90(暂无昵称), createdTime=Sat Apr 18 00:00:00 CST 2020, time=2020-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902029, encodeId=a28d902029d1, content=请问过来人，投稿后只有通讯才能收到邮件吗？投稿的几个状态是啥？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=两难不难, createdTime=Wed Nov 25 07:53:35 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187768, encodeId=70b9118e76879, content=偏重的研究方向：临床营养 经验分享：EJCN meta分析投稿过程 2019.8.23投稿 2019.11.4 一修，12.17日返回修改稿 2020.1.6接收并二修，1.13返回 2020.1.17三修，1.20返回（有关通讯作者的小插曲） 2020.2.19接收 2020.2.28清样校队（未收到邮件，2.9日返回清样修改） 2020.3.13 EJCN上见刊 pubmed检索到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7ccb5091546, createdName=145d4526m90(暂无昵称), createdTime=Mon Jan 24 18:45:49 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090233, encodeId=46501090233c8, content=什么叫俢回？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090234, encodeId=371b109023434, content=俢回包括几个方面？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600232, encodeId=9c6d60023229, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：20.02.19 接收 20.02.11 decision 小修 20.01.27 一修提交 19.12.14 Waiting for Revision（due on 20.03.12）大修 19.09.17 in review (under review) 19.07.24 submission , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=09535185854, createdName=14707d35m85暂无昵称, createdTime=Sat May 23 10:53:10 CST 2020, time=2020-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581432, encodeId=e6315814326e, content=怎么就一个review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuCa1ZaFh5Zdh1foqG1yB0ykFycWxPtg8y2iaVXY2KzrTc2R2UzasWspet9CmDHK0FJkutZYBvF7fx/0, createdBy=9fdd2081770, createdName=1521f25362m, createdTime=Fri Dec 13 00:00:00 CST 2019, time=2019-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564560, encodeId=4aed56456067, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：Meta 分析。18.11.21投稿，当即编辑发来邮件要求修改格式，连续修改了三次总算过格式关。11.28日通知通过初审送外审。11.17日退稿。俩审稿人都给了不多但很中肯的意见（可能我水平太差懒得多提），我也认识自己的差距，准备好好改投别家。都一致评我英语太差。总体来说效率很高，没有耽误太久，编辑来信中也提到中稿率约25%。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKJ73fWSxHh3xvG6CRmkSC454TlmZGCL5nXyJYuwwrvJtX7y37Q0W3jVTNKAXJvK0cZlXW85O4BdQ/132, createdBy=13532450097, createdName=王尛象, createdTime=Mon Dec 17 00:00:00 CST 2018, time=2018-12-17, status=1, ipAttribution=)]

2018-12-17 王尛象

审稿速度:1.0 | 投稿命中率:25.0
经验分享：Meta 分析。18.11.21投稿，当即编辑发来邮件要求修改格式，连续修改了三次总算过格式关。11.28日通知通过初审送外审。11.17日退稿。俩审稿人都给了不多但很中肯的意见（可能我水平太差懒得多提），我也认识自己的差距，准备好好改投别家。都一致评我英语太差。总体来说效率很高，没有耽误太久，编辑来信中也提到中稿率约25%。

167 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务